Cancer of the Breast
- 10 January 1980
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 302 (2), 78-90
- https://doi.org/10.1056/nejm198001103020203
Abstract
Newer Forms of Hormone Therapy: AntiestrogensAntiestrogens were developed as antifertility drugs. Instead, they induce ovulation in infertile women, and they may also cause regression of breast-cancer lesions. One of these drugs, tamoxifen, has been approved for general use in the treatment of breast cancer. Two others, nafoxidine and clomiphene, have been studied extensively in clinical trials.187 Tamoxifen is usually administered as a 10-mg tablet twice daily, even though its biologic half-life exceeds seven days.188 If the effect of tamoxifen depends on its competition with estrogen for binding sites in tumor-cell cytoplasm, we would expect to see a dose response . . .Keywords
This publication has 79 references indexed in Scilit:
- Antihormone treatment of stage IV breast cancerCancer, 1979
- Tamoxifen flare in advanced breast cancerJAMA, 1978
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- TamoxifenDrugs, 1978
- Clinical trial of nafoxidine in advanced breast cancerMedical and Pediatric Oncology, 1978
- Tamoxifen (Antiestrogen) Therapy in Advanced Breast CancerAnnals of Internal Medicine, 1977
- Antiestrogens in treatment of breast cancerCancer, 1977
- Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course.BMJ, 1977
- Antiestrogens in the treatment of breast cancerCancer Treatment Reviews, 1976
- Antioestrogens in Treatment of Breast Cancer: Value of Nafoxidine in 52 Advanced CasesBMJ, 1974